Revenue 2025
$275.1M
Reports in USD
Net Income 2025
$22.7M
8.2% net margin
Debt / EBITDA
0.5x
Strong financial headroom
Segments
B2B
Flavors & Fragrances
Geography
Global
Israel, Europe, North America
1 Company Profile
Tarpaz Industries (TRPZ) is a professional flavour-and-fragrance ingredients company traded on the Tel Aviv Stock Exchange. Tarpaz produces and markets flavour extracts, fragrance compounds, and food colours for the food, beverage, cosmetics and pharmaceutical industries. Tarpaz belongs to the B2B specialty-chemicals category — a small but professional supplier in global markets, competing through technical expertise rather than scale. The company operates across several geographies (Israel, Europe, North America) and reports in USD. 2025 revenue: $275M. Strong financial position: Debt/EBITDA of 0.5× — room for expansion through acquisitions.
| Activity | Feature |
|---|
| Flavour extracts | Food, beverages |
| Fragrance compounds | Cosmetics, cleaning |
| Food colours | Food and pharmaceuticals |
| Custom solutions | Dedicated R&D for the customer |
Source: Annual 2025, Maya TASE
2 Key Financial Observations
This summary is not a recommendation. It is a factual list of key financial metrics.
Key Metrics 2025
| Metric | Value |
|---|
| Revenue | $275.1M |
| EBITDA | $63.5M |
| EBITDA Margin | 23.1% |
| Net Income | $22.7M |
| Net Margin | 8.2% |
| Debt / EBITDA | 0.5x |
Missing Data
| Metric | Status |
|---|
| Exact EPS | Requires verification |
| Market Cap | Requires verification |
| Segments breakdown | Requires full report |
| Cash and cash equivalents | Requires full report |
Missing data: Exact EPS, Market Cap, Segments breakdown, Cash and cash equivalents.
Debt / EBITDA (Financial)
3 Industry & Competitive Context
Flavors & Fragrances ingredients. A mature, competitive global market dominated by giant companies. Trends: demand for natural flavors, expansion of processed food, expansion of cosmetics, "clean label".
| Competitor | Exchange | Difference |
|---|
| Givaudan | SIX | Swiss giant — 30x the size of Tarpaz |
| IFF (Intl Flavors) | NYSE | American giant |
| Symrise | Xetra | German giant |
| Firmenich | — | Private |
4 Risk Factors
| Risk | Context |
|---|
| Dependence on large customers | B2B specialty — possible dependence on key customers |
| Competition vs Givaudan/IFF | Giants with massive R&D |
| Raw material prices | Volatile (plant-based materials, ethanol) |
| FX exposure | Reports in USD, international operations |
| Relatively small size | Limited capacity to invest in R&D |
5 Analytical Lens — The Questions We Ask
In professional company analysis, the question is not "is this good?" but rather "through which lenses must this company be examined so that we do not miss what matters most?" At Bakshi Finance, every analysis passes through six lenses.
This framework is intended to structure analysis, not to produce an investment conclusion.
Growth
What is the geographic growth pace? Acquisitions or organic?
Profitability
EBITDA margin 23% — strong for the segment. What is the trend?
Leverage
Debt / EBITDA 0.5x — low. A strategic advantage for acquisitions?
Competitive Position
Tarpaz versus Givaudan — how can margins be preserved?
Management Quality
Historical execution and M&A strategy.
Business Complexity
An international company in a professional niche — how should an investor value it?
6 Scenario Framework
Scenarios are descriptive, not predictive. They outline possible conditions, not expected outcomes.
These scenarios carry no probability assessment, no preferred direction, and no expectation regarding which, if any, will materialise.
Constructive Scenario — if the following conditions hold:
A strategic acquisition using the available financial headroom, geographic expansion, margins rise.
Base Scenario — if current trends continue:
Growth of 3-5%, margins stable at 22-24%, net income grows with EBITDA.
Adverse Scenario — if the following risks materialise:
Pricing pressure from major customers, rising raw-material costs, adverse FX.
Scenarios describe conditions, not forecasts. There is no preferred direction and no probability assessment expressed in this framework.
7 How to Think About This Company
Tarpaz is a small-to-mid-cap B2B specialty-chemicals company in the flavours & fragrances segment. The core question in analysing Tarpaz is not "does it build brands" (it is B2B, not consumer), but rather "does it have a technical or customer-relationship advantage that allows it to sustain 20%+ margins against giants like Givaudan?"
The critical variables: (a) customer concentration — do the top 5 customers represent 50% of revenue? (b) R&D spend as a percentage of revenue — sufficient to remain relevant? (c) acquisitions — with Debt/EBITDA of 0.5× there is room, but value is realised only at the right price.
Where the analysis may go wrong: First error — treating Tarpaz as a generic chemicals company (it is specialty, with premium pricing). Second error — underestimating the strength of the larger competitors. Third error — viewing low debt as an automatic advantage — value is realised only when capital is deployed well.
What distinguishes professional analysis of Tarpaz. Professional analysis addresses three things: (a) portfolio breadth (number of products × number of customers); (b) margins versus Givaudan/IFF; (c) ROIC on past acquisitions.
The difference between surface-level analysis and professional thinking often lies in the variables that are not immediately visible.
The difference between surface-level analysis and professional thinking often lies in the variables that are not immediately visible.
8 Sources & Data
| # | Source | Date | Type |
|---|
| 1 | Tarpaz — 2025 Annual Report | March 2026 | Official — TASE |
| 2 | maya.tase.co.il | April 2026 | Official — Stock Exchange |
Missing: Exact EPS, Market Cap, Segments breakdown, Cash and cash equivalents.
